A research programme by the Access to Medicine Foundation
  • Best practices
  • Best practice: Leading examples of platforms to track access...
Best practice

Leading examples of platforms to track access activities

Company:

Johnson & Johnson, Roche Holding AG

What:

Systems that enable them to track how local access strategies are implemented, and how activities progress.

Region:

Global

Aim:

To monitor and measure the outcomes and progress of its access-to-medicine activities.

Context:

Ensuring continuous improvement in access can only be possible through regular, transparent monitoring and evaluation.

Johnson & Johnson represents best practice for its transparency in publicly disclosing access-to-medicine outcomes. With Roche, it also represents best practice for robust performance management in access activities.

How does Johnson & Johnson track access activities?
Since 2016, Johnson & Johnson publishes all its goals and targets for access, and progress made. For example, on its goal to deliver innovative healthcare access and trainings to impact a billion lives in underserved areas, it reports being on track to make HIV/AIDS therapy accessible to a total of 130,000 adults and 5,000 children by 2020. So far under this programme, 38,500 adults and 630 children have received HIV/AIDS treatment.

In its transparency in providing information about its progress, Johnson & Johnson also meets external stakeholders’ expectations for public reporting, enabling accountability for its activities. It commits to the UN Sustainable Development Goals and has measurable targets: Health for Humanity goals, incorporating access-related objectives. Through these, the company demonstrates that it considers access to be relevant for its own sustainability.

As well as being transparent, Johnson & Johnson has a robust performance management system to monitor and measure the outcomes and progress of its access-to-medicine activities. This system, which the company adapts to each of its working groups on access-related strategies, collect information about medicines covered by the company’s GCSO through its includes its Market Access Product Dashboards. For at least one access initiative (New Horizons, advancing HIV care for children), Johnson & Johnson uses a logic model framework (a tool for performance management) and an impact assessment plan.

How does Roche track access activities?
Like Johnson & Johnson, Roche stands out in performance management for access. It too has an analytics system (its “Patient Access Dashboard”) that supports the identification of access-related challenges and relevant stakeholders to engage with to provide access plans that are specific to each country; it also underpins internal goals by tracking outcomes of activities. 

One goal was to increase access to treatment for people with HER2+ breast cancer and blood cancers. Using its system to test access across 14 low-and middle-income countries, Roche achieved its goal before the end of the set period. It has since extended its country scope and aims to scale up to reach a new goal and continue to expand.

What makes this a best practice?
Both Roche and Johnson & Johnson aim to create value in global access to medicine, with systems that enable them to track how local access strategies are implemented, and how activities progress. These “dashboards” gather best practice and incentivise employees to consider access challenges across operations: such joined-up thinking makes success more likely toward addressing unmet needs of patients globally.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.